Orales Heilmittel mit Verzögerter Freisetzung, enthaltend Tolperisonhydrochlorid, Seine Herstellung und Verwendung

Details

Veröffentlichungs-Nr.

EP4721731

Anmeldetag

20. November 2024

Veröffentlichung

8. April 2026

Rechtsraum

EP

IPC

(RICHTER GEDEON NYRT et al.)(PANACEA BIOTEC LTD et al.)(IGNYTA INC et al.)

Abstract

The invention relates to sustained release oral medicinal product containing tolperisone, that contains tolperisone hydrochloride, betaine hydrochloride and a hydrophilic matrix-forming material and which medicinal product releases at least 80% of the tolperisone hydrochloride active ingredient within 6 hours. Furthermore, the invention relates to the manufacture of the above medicinal product and to its use.

Anmelder

Firma

MEDITOP Gyógyszeripari Kft.

Land

🇭🇺 Ungarn